Clinica Baviera SA
MAD:CBAV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Clinica Baviera SA
MAD:CBAV
|
ES |
|
Surteco Group SE
XETRA:SUR
|
DE |
|
Nongshim Co Ltd
KRX:004370
|
KR |
|
Focus Universal Inc
NASDAQ:FCUV
|
US |
|
B
|
BIG Camera Corporation PCL
SET:BIG
|
TH |
Wall St Price Targets
CBAV Price Targets Summary
Clinica Baviera SA
According to Wall Street analysts, the average 1-year price target for CBAV is 72.93 EUR with a low forecast of 72.22 EUR and a high forecast of 75.08 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CBAV's stock price target?
Price Target
72.93
EUR
According to Wall Street analysts, the average 1-year price target for CBAV is 72.93 EUR with a low forecast of 72.22 EUR and a high forecast of 75.08 EUR.
What is the Revenue forecast for Clinica Baviera SA?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Clinica Baviera SA?
Projected CAGR
-15%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is -15%.
What is the Operating Income forecast for Clinica Baviera SA?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 24%. The projected CAGR for the next 3 years is 12%.
What is the Pre-Tax Income forecast for Clinica Baviera SA?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 55%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Clinica Baviera SA?
Projected CAGR
14%
The compound annual growth rate for Net Income over the next 3 years is 14%.
